Literature DB >> 11845233

Complete mutation scan of the human Fas ligand gene: linkage studies in Type I diabetes mellitus families.

R L Nolsøe1, O P Kristiansen, Z M Larsen, J Johannesen, F Pociot, T Mandrup-Poulsen.   

Abstract

AIMS/HYPOTHESIS: Type I (insulin-dependent) diabetes mellitus is the result of a T-cell regulated selective destruction of pancreatic beta cells. There is evidence that the apoptosis inducing T-cell effector, Fas ligand (FasL) could be involved in the pathogenesis of Type I diabetes, probably because FasL-mediated apoptosis is important in maintaining peripheral self-tolerance and in down-regulating an immune response. We therefore evaluated the human FasL gene FASL on chromosome 1q23 as a candidate susceptibility gene for Type I diabetes.
METHODS: The entire FASL (promoter, exons 1-4 and 3'UTR) was scanned for polymorphisms using single strand conformational polymorphism-heteroduplex analysis and direct sequencing.
RESULTS: We identified two novel polymorphisms, a g-C843T and a g-A475T, in a negative regulatory region of the promoter. A Danish Type I diabetes family collection of 1143 subjects comprising 257 families (420 affected and 252 unaffected offspring) was typed for the g-C843T polymorphism and for a FASL microsatellite. Haplotypes were established and data were analysed using the extended transmission disequilibrium test. CONCLUSION/
INTERPRETATION: We found no overall evidence for linkage in the presence of association of the FASL polymorphism to Type I diabetes and conclude that FASL does not contribute to the genetic susceptibility to Type I diabetes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11845233     DOI: 10.1007/s125-002-8254-7

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  3 in total

1.  Death pathways in T cell homeostasis and their role in autoimmune diabetes.

Authors:  Matthew A Gronski; Michael Weinem
Journal:  Rev Diabet Stud       Date:  2006-08-10

2.  Genomic analysis of Fas and FasL genes and absence of correlation with disease progression in AIDS.

Authors:  A Vasilescu; S C Heath; G Diop; H Do; T Hirtzig; H Hendel; S Bertin-Maghit; J Rappaport; A Therwath; G M Lathrop; F Matsuda; J-F Zagury
Journal:  Immunogenetics       Date:  2004-03-23       Impact factor: 2.846

3.  Dominant inhibition of Fas ligand-mediated apoptosis due to a heterozygous mutation associated with autoimmune lymphoproliferative syndrome (ALPS) Type Ib.

Authors:  Lilia L Bi; George Pan; T Prescott Atkinson; Lixin Zheng; Janet K Dale; Christopher Makris; Vishnu Reddy; Jay M McDonald; Richard M Siegel; Jennifer M Puck; Michael J Lenardo; Stephen E Straus
Journal:  BMC Med Genet       Date:  2007-07-02       Impact factor: 2.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.